Hui Cai

Corporate Officer/Principal bei WUXI APPTEC CO., LTD.

Consumer Services

Health Technology

Profil

Hui Cai is currently the VP-Corporate Alliances & Communications at WuXi AppTec Co., Ltd.
Prior to this, Dr. Cai held the position of Vice President-Corporate Development at HUYA Bioscience International LLC and President at Inflexion BioPartners, Inc. Dr. Cai's education includes a doctorate from The Scripps Research Institute, undergraduate and graduate degrees from Peking University, and an MBA from the University of California San Diego.

Aktive Positionen von Hui Cai

Unternehmen	Position	Beginn
WUXI APPTEC CO., LTD.	Corporate Officer/Principal	-

Alle aktiven Positionen von Hui Cai

Ehemalige bekannte Positionen von Hui Cai

Unternehmen	Position	Ende
Inflexion BioPartners, Inc.	President	-
HUYA Bioscience International LLC HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Hui Cai im Detail an

Ausbildung von Hui Cai

The Scripps Research Institute	Doctorate Degree
Peking University	Graduate Degree
University of California San Diego	Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Hui Cai im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
WUXI APPTEC CO., LTD.	Health Technology

Private Unternehmen	2
HUYA Bioscience International LLC HUYA Bioscience International LLC Pharmaceuticals: MajorHealth Technology HUYA Bioscience International LLC develops biopharmaceutical products. It sources pharmaceutical innovation originating in China for global development in international markets. It's lead immune-oncology lead product, HBI-8000, already approved in China, is now in registration trials in Japan and Korea for lymphoma and in clinical trials in the U.S. for various solid tumor indications in combination with the checkpoint inhibitor nivolumab. The company was founded by Mireille Gillings in 2004 and is headquartered in San Diego, CA.	Health Technology
Inflexion BioPartners, Inc.